Related Experiment Videos
[Tissue parameters of prognosis in cancer of the breast]
1Institut Curie, Paris, France.
Bulletin Du Cancer
|December 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Veliparib monotherapy following carboplatin/paclitaxel plus veliparib combination therapy in patients with germline BRCA-associated advanced breast cancer: results of exploratory analyses from the phase III BROCADE3 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosis.
European journal of cancer (Oxford, England : 1990)·2021
First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
[Telemonitoring in Oncology: A French overview between 2022 and 2025].
Bulletin du cancer·2026
[Antibiotic use following pediatric hematopoietic stem cell transplantation (SFGM-TC)].
Bulletin du cancer·2026
[Evolving strategies for relapsed multiple myeloma: Toward personalized treatment in 2026].
Bulletin du cancer·2026